Loblaw Companies Limited has announced a profit of $751 million for the second quarter of 2026, reflecting a significant increase from the same period last year. This growth is attributed to higher revenue and increased sales across its grocery and pharmacy divisions.
The company's revenue for the quarter reached $16.4 billion, marking an 11.3% increase compared to the previous year. Same-store sales in the Food Retail segment, which includes Loblaw's grocery stores, rose by 1.5%, while the Drug Retail segment, encompassing Shoppers Drug Mart, saw a 3.9% increase. E-commerce sales also experienced a notable boost, climbing 19.6%.
Loblaw's operating income stood at $1.13 billion, a 43% rise from the same quarter in 2025. The adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) was $1.78 billion, up 11.3% year-over-year. The company's gross profit margin was 30.8%, slightly down by 10 basis points, primarily due to changes in the sales mix within the Drug Retail category.
The strong performance is partly driven by the growing popularity of discount grocery stores like No Frills and Maxi, which have attracted more cost-conscious shoppers seeking value. Loblaw's strategic focus on expanding these discount banners has resonated with Canadian consumers, contributing to the overall sales growth.
Looking ahead, Loblaw is scheduled to release its third-quarter earnings on July 30, 2026. Investors and analysts will be keen to see if the company can maintain this upward trajectory and continue to capitalize on the demand for affordable grocery options.